LYBALVI
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88489837
- Registration number
- 6913410
- Mark type
- Design + words
- Filed
- 26 Jun 2019
- Published for opposition
- 29 Oct 2019
- Registered
- 29 Nov 2022
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
Owner
- Alkermes Pharma Ireland Limited, Dublin 4, IE
- Alkermes Pharma Ireland Limited, Dublin 4, IE
- Alkermes Pharma Ireland Limited, Dublin 4, IE
Prosecution history
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Oct 2022 — ASSIGNED TO EXAMINER
- 04 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Dec 2021 — USE AMENDMENT FILED
- 07 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2022 — SOU EXTENSION 4 GRANTED
- 17 Dec 2021 — SOU EXTENSION 4 FILED
- 28 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 06 Oct 2021 — ASSIGNED TO EXAMINER
- 25 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED